 Lorna Browne
Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 36 | 2025 | 3897 | 3.580 |
Why?
| | Tomography, X-Ray Computed | 21 | 2025 | 2772 | 3.080 |
Why?
| | Heart Defects, Congenital | 11 | 2025 | 909 | 2.430 |
Why?
| | Computed Tomography Angiography | 6 | 2025 | 146 | 1.880 |
Why?
| | Magnetic Resonance Angiography | 9 | 2025 | 251 | 1.880 |
Why?
| | Magnetic Resonance Imaging, Cine | 13 | 2025 | 213 | 1.740 |
Why?
| | Vascular Stiffness | 12 | 2024 | 486 | 1.730 |
Why?
| | Hemodynamics | 18 | 2025 | 1116 | 1.570 |
Why?
| | Aortic Coarctation | 5 | 2025 | 78 | 1.550 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 4 | 2022 | 94 | 1.280 |
Why?
| | Hypertension, Pulmonary | 9 | 2024 | 1957 | 1.280 |
Why?
| | Radiation Dosage | 4 | 2025 | 196 | 1.190 |
Why?
| | Pulmonary Artery | 13 | 2025 | 1127 | 1.190 |
Why?
| | Coronary Angiography | 3 | 2025 | 343 | 1.090 |
Why?
| | Child | 57 | 2025 | 22680 | 1.070 |
Why?
| | Aorta | 12 | 2024 | 439 | 1.050 |
Why?
| | Coronary Vessels | 5 | 2022 | 247 | 1.020 |
Why?
| | Tetralogy of Fallot | 7 | 2025 | 78 | 1.010 |
Why?
| | Heart | 6 | 2025 | 626 | 0.990 |
Why?
| | Pulmonary Valve | 4 | 2025 | 102 | 0.950 |
Why?
| | Infant | 27 | 2025 | 10064 | 0.940 |
Why?
| | Imaging, Three-Dimensional | 10 | 2025 | 587 | 0.920 |
Why?
| | Heart Ventricles | 9 | 2025 | 754 | 0.880 |
Why?
| | Retrospective Studies | 35 | 2025 | 17269 | 0.870 |
Why?
| | Child, Preschool | 25 | 2025 | 11837 | 0.840 |
Why?
| | Infant, Newborn | 21 | 2025 | 6437 | 0.840 |
Why?
| | Heart Valve Prosthesis Implantation | 3 | 2025 | 202 | 0.770 |
Why?
| | Blood Flow Velocity | 9 | 2024 | 420 | 0.770 |
Why?
| | Stenosis, Pulmonary Vein | 1 | 2023 | 19 | 0.760 |
Why?
| | Coronary Circulation | 3 | 2022 | 136 | 0.730 |
Why?
| | Adolescent | 41 | 2025 | 22485 | 0.720 |
Why?
| | Pulmonary Veins | 1 | 2023 | 106 | 0.710 |
Why?
| | Humans | 97 | 2025 | 145491 | 0.680 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2020 | 21 | 0.640 |
Why?
| | Body Surface Area | 1 | 2020 | 34 | 0.640 |
Why?
| | Aorta, Thoracic | 5 | 2023 | 286 | 0.620 |
Why?
| | Ventricular Dysfunction, Left | 6 | 2020 | 394 | 0.620 |
Why?
| | Foreign Bodies | 1 | 2021 | 110 | 0.610 |
Why?
| | Ventricular Function, Left | 6 | 2023 | 539 | 0.560 |
Why?
| | Photons | 4 | 2025 | 73 | 0.550 |
Why?
| | Anesthesia | 1 | 2022 | 258 | 0.540 |
Why?
| | Glycogen Storage Disease | 1 | 2018 | 19 | 0.540 |
Why?
| | Diagnostic Imaging | 2 | 2020 | 342 | 0.540 |
Why?
| | Osteomyelitis | 2 | 2012 | 144 | 0.540 |
Why?
| | Male | 53 | 2025 | 72817 | 0.540 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2023 | 411 | 0.530 |
Why?
| | Female | 54 | 2025 | 78763 | 0.530 |
Why?
| | Pulse Wave Analysis | 7 | 2022 | 267 | 0.530 |
Why?
| | Predictive Value of Tests | 8 | 2025 | 2129 | 0.510 |
Why?
| | Echocardiography | 6 | 2023 | 648 | 0.490 |
Why?
| | Bronchiolitis | 1 | 2017 | 87 | 0.480 |
Why?
| | Arteries | 1 | 2018 | 261 | 0.480 |
Why?
| | Scimitar Syndrome | 1 | 2016 | 9 | 0.480 |
Why?
| | Heart Rate | 1 | 2020 | 859 | 0.470 |
Why?
| | Hemoptysis | 1 | 2016 | 35 | 0.470 |
Why?
| | Postoperative Complications | 5 | 2020 | 2962 | 0.460 |
Why?
| | Staphylococcal Infections | 2 | 2012 | 391 | 0.460 |
Why?
| | Pregnancy Trimester, Third | 3 | 2025 | 118 | 0.460 |
Why?
| | Spermatocele | 1 | 2015 | 2 | 0.450 |
Why?
| | Ultrasonography | 3 | 2015 | 784 | 0.440 |
Why?
| | Phantoms, Imaging | 3 | 2025 | 159 | 0.440 |
Why?
| | Scrotum | 1 | 2015 | 25 | 0.440 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.430 |
Why?
| | Ventricular Dysfunction, Right | 5 | 2022 | 248 | 0.430 |
Why?
| | Lung Diseases, Interstitial | 2 | 2019 | 660 | 0.430 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.430 |
Why?
| | Image Enhancement | 2 | 2022 | 200 | 0.430 |
Why?
| | Cardiac Surgical Procedures | 4 | 2025 | 613 | 0.430 |
Why?
| | Myocardium | 2 | 2017 | 932 | 0.430 |
Why?
| | Pulmonary Valve Insufficiency | 3 | 2025 | 48 | 0.430 |
Why?
| | Testis | 1 | 2015 | 162 | 0.420 |
Why?
| | Pulmonary Atresia | 2 | 2025 | 22 | 0.400 |
Why?
| | Pancreatitis, Chronic | 2 | 2025 | 64 | 0.400 |
Why?
| | Fetal Heart | 2 | 2024 | 56 | 0.400 |
Why?
| | Testicular Neoplasms | 1 | 2015 | 111 | 0.400 |
Why?
| | Cardiac Catheterization | 6 | 2025 | 570 | 0.390 |
Why?
| | Fontan Procedure | 3 | 2020 | 188 | 0.390 |
Why?
| | Heart Valve Diseases | 3 | 2024 | 152 | 0.390 |
Why?
| | Preoperative Care | 2 | 2017 | 380 | 0.390 |
Why?
| | Stress, Mechanical | 5 | 2024 | 495 | 0.390 |
Why?
| | Arterial Pressure | 3 | 2019 | 134 | 0.380 |
Why?
| | Anesthesia, General | 2 | 2024 | 121 | 0.360 |
Why?
| | Community-Acquired Infections | 2 | 2012 | 177 | 0.360 |
Why?
| | Pulmonary Valve Stenosis | 2 | 2025 | 27 | 0.360 |
Why?
| | Regional Blood Flow | 3 | 2024 | 515 | 0.350 |
Why?
| | Growth Plate | 1 | 2012 | 39 | 0.350 |
Why?
| | Pulmonary Circulation | 3 | 2025 | 430 | 0.340 |
Why?
| | Severe Combined Immunodeficiency | 1 | 2011 | 22 | 0.340 |
Why?
| | Young Adult | 16 | 2025 | 14192 | 0.340 |
Why?
| | Aortic Valve | 3 | 2024 | 364 | 0.330 |
Why?
| | Intestinal Obstruction | 1 | 2011 | 55 | 0.330 |
Why?
| | Peritonitis | 1 | 2011 | 83 | 0.330 |
Why?
| | Contrast Media | 4 | 2025 | 500 | 0.320 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2020 | 117 | 0.310 |
Why?
| | Lung Diseases | 2 | 2014 | 783 | 0.310 |
Why?
| | Myocardial Stunning | 1 | 2009 | 4 | 0.310 |
Why?
| | Aortic Diseases | 3 | 2020 | 127 | 0.300 |
Why?
| | Radiology | 2 | 2022 | 174 | 0.300 |
Why?
| | Aortic Arch Syndromes | 1 | 2009 | 2 | 0.300 |
Why?
| | Coronary Vessel Anomalies | 1 | 2009 | 39 | 0.300 |
Why?
| | Postoperative Care | 1 | 2011 | 286 | 0.300 |
Why?
| | Fetus | 3 | 2025 | 804 | 0.290 |
Why?
| | Reproducibility of Results | 10 | 2024 | 3424 | 0.290 |
Why?
| | Cardiology | 2 | 2022 | 365 | 0.290 |
Why?
| | Radiography, Abdominal | 2 | 2024 | 44 | 0.290 |
Why?
| | Heart Diseases | 2 | 2022 | 342 | 0.290 |
Why?
| | Technetium Tc 99m Medronate | 1 | 2008 | 5 | 0.280 |
Why?
| | Diagnosis, Differential | 5 | 2018 | 1507 | 0.280 |
Why?
| | Puberty, Precocious | 1 | 2008 | 12 | 0.270 |
Why?
| | Ultrasonography, Prenatal | 3 | 2025 | 294 | 0.270 |
Why?
| | Turner Syndrome | 2 | 2019 | 64 | 0.270 |
Why?
| | Ventricular Function, Right | 5 | 2022 | 296 | 0.270 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 105 | 0.270 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 197 | 0.270 |
Why?
| | Cardiovascular Diseases | 5 | 2025 | 2185 | 0.260 |
Why?
| | Hypothyroidism | 1 | 2008 | 67 | 0.260 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2025 | 24 | 0.260 |
Why?
| | Ovary | 1 | 2008 | 227 | 0.240 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2025 | 289 | 0.230 |
Why?
| | Perfusion Imaging | 3 | 2024 | 65 | 0.230 |
Why?
| | Abdominal Fat | 1 | 2025 | 50 | 0.220 |
Why?
| | Risk | 2 | 2018 | 917 | 0.220 |
Why?
| | Biopsy | 3 | 2018 | 1081 | 0.220 |
Why?
| | Artifacts | 2 | 2025 | 143 | 0.220 |
Why?
| | Greenhouse Gases | 1 | 2025 | 9 | 0.220 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 251 | 0.220 |
Why?
| | Echocardiography, Four-Dimensional | 1 | 2024 | 9 | 0.220 |
Why?
| | Treatment Outcome | 13 | 2025 | 11831 | 0.210 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 127 | 0.210 |
Why?
| | Respiration | 2 | 2022 | 206 | 0.210 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2024 | 3917 | 0.210 |
Why?
| | Cross-Over Studies | 2 | 2024 | 607 | 0.210 |
Why?
| | Infant, Premature | 2 | 2023 | 619 | 0.210 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2025 | 2582 | 0.200 |
Why?
| | Echocardiography, Doppler | 1 | 2024 | 114 | 0.200 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2025 | 780 | 0.200 |
Why?
| | Gastrectomy | 1 | 2025 | 162 | 0.200 |
Why?
| | Health Resources | 1 | 2025 | 130 | 0.200 |
Why?
| | Gestational Age | 2 | 2024 | 988 | 0.200 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 106 | 0.190 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2024 | 196 | 0.190 |
Why?
| | Prenatal Diagnosis | 1 | 2025 | 196 | 0.190 |
Why?
| | Iothalamic Acid | 1 | 2022 | 5 | 0.190 |
Why?
| | Heart Valve Prosthesis | 1 | 2024 | 132 | 0.180 |
Why?
| | Virtual Reality | 1 | 2024 | 82 | 0.180 |
Why?
| | Hepatic Veins | 1 | 2021 | 32 | 0.170 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2025 | 299 | 0.170 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 5 | 0.170 |
Why?
| | Electric Power Supplies | 1 | 2021 | 48 | 0.170 |
Why?
| | Vascular Malformations | 1 | 2021 | 51 | 0.170 |
Why?
| | Hemangiosarcoma | 1 | 2021 | 23 | 0.160 |
Why?
| | Case-Control Studies | 5 | 2019 | 3619 | 0.160 |
Why?
| | Pediatrics | 1 | 2009 | 1121 | 0.160 |
Why?
| | Heart Neoplasms | 1 | 2021 | 56 | 0.160 |
Why?
| | Portal Vein | 1 | 2021 | 116 | 0.160 |
Why?
| | Patient Compliance | 1 | 2024 | 587 | 0.160 |
Why?
| | Neoplasms, Second Primary | 1 | 2021 | 102 | 0.150 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 95 | 0.150 |
Why?
| | Heart Function Tests | 1 | 2019 | 59 | 0.150 |
Why?
| | Sarcopenia | 1 | 2021 | 91 | 0.150 |
Why?
| | Gastric Bypass | 1 | 2021 | 126 | 0.150 |
Why?
| | Oxygen Consumption | 2 | 2025 | 718 | 0.150 |
Why?
| | Follow-Up Studies | 4 | 2021 | 5426 | 0.150 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 239 | 0.150 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.150 |
Why?
| | Sensitivity and Specificity | 3 | 2024 | 2002 | 0.150 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 10 | 0.150 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 16 | 0.150 |
Why?
| | Chorea | 1 | 2019 | 13 | 0.150 |
Why?
| | Cardiovascular Abnormalities | 1 | 2019 | 15 | 0.150 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2020 | 138 | 0.140 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 197 | 0.140 |
Why?
| | Kidney | 3 | 2022 | 1498 | 0.140 |
Why?
| | Marfan Syndrome | 1 | 2018 | 46 | 0.140 |
Why?
| | Eating | 1 | 2021 | 388 | 0.140 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 94 | 0.140 |
Why?
| | Cloaca | 1 | 2018 | 52 | 0.140 |
Why?
| | Pediatric Obesity | 1 | 2025 | 637 | 0.140 |
Why?
| | Urogenital Abnormalities | 1 | 2018 | 71 | 0.140 |
Why?
| | Shear Strength | 1 | 2018 | 73 | 0.130 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 107 | 0.130 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 272 | 0.130 |
Why?
| | Thermodilution | 1 | 2017 | 16 | 0.130 |
Why?
| | Liver Function Tests | 1 | 2018 | 105 | 0.130 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2017 | 23 | 0.130 |
Why?
| | Blood Vessels | 1 | 2018 | 167 | 0.130 |
Why?
| | Obesity, Morbid | 1 | 2021 | 288 | 0.130 |
Why?
| | Cholangitis, Sclerosing | 1 | 2018 | 61 | 0.130 |
Why?
| | Stroke Volume | 4 | 2022 | 654 | 0.130 |
Why?
| | Adult | 13 | 2025 | 40707 | 0.120 |
Why?
| | Thoracic Diseases | 1 | 2016 | 11 | 0.120 |
Why?
| | Sleep | 1 | 2024 | 891 | 0.120 |
Why?
| | Prospective Studies | 7 | 2024 | 8039 | 0.120 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2016 | 36 | 0.120 |
Why?
| | Perfusion | 1 | 2017 | 249 | 0.120 |
Why?
| | Vascular Remodeling | 1 | 2018 | 209 | 0.120 |
Why?
| | Dilatation, Pathologic | 3 | 2024 | 61 | 0.120 |
Why?
| | Systole | 3 | 2022 | 181 | 0.120 |
Why?
| | Prognosis | 5 | 2021 | 4323 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 894 | 0.120 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 257 | 0.120 |
Why?
| | Prevalence | 1 | 2023 | 2855 | 0.110 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 287 | 0.110 |
Why?
| | Quality Improvement | 1 | 2024 | 1294 | 0.110 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2022 | 625 | 0.110 |
Why?
| | Age Factors | 5 | 2024 | 3340 | 0.110 |
Why?
| | Fibrosis | 1 | 2017 | 551 | 0.110 |
Why?
| | Coronary Thrombosis | 1 | 2015 | 27 | 0.110 |
Why?
| | Metformin | 1 | 2018 | 324 | 0.110 |
Why?
| | Calcinosis | 1 | 2017 | 235 | 0.110 |
Why?
| | Mutation | 2 | 2024 | 4093 | 0.110 |
Why?
| | Exercise Test | 1 | 2017 | 628 | 0.110 |
Why?
| | Toes | 1 | 2014 | 16 | 0.100 |
Why?
| | Risk Assessment | 4 | 2018 | 3759 | 0.100 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 6070 | 0.100 |
Why?
| | Research Design | 1 | 2020 | 1134 | 0.100 |
Why?
| | Liver Transplantation | 1 | 2021 | 831 | 0.100 |
Why?
| | Arteriovenous Malformations | 1 | 2014 | 32 | 0.100 |
Why?
| | Disease Progression | 2 | 2018 | 2862 | 0.100 |
Why?
| | Edema | 1 | 2014 | 124 | 0.100 |
Why?
| | Vocal Cord Paralysis | 1 | 2012 | 27 | 0.090 |
Why?
| | Ligation | 1 | 2012 | 91 | 0.090 |
Why?
| | Reference Values | 2 | 2024 | 797 | 0.090 |
Why?
| | Comorbidity | 1 | 2017 | 1659 | 0.090 |
Why?
| | Surgical Instruments | 1 | 2012 | 51 | 0.090 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2012 | 51 | 0.090 |
Why?
| | Barium Sulfate | 1 | 2011 | 14 | 0.090 |
Why?
| | Gadolinium DTPA | 1 | 2012 | 70 | 0.090 |
Why?
| | North America | 2 | 2022 | 312 | 0.080 |
Why?
| | Lung | 2 | 2023 | 4103 | 0.080 |
Why?
| | Biomechanical Phenomena | 3 | 2020 | 860 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1965 | 0.080 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5891 | 0.080 |
Why?
| | Bronchi | 1 | 2012 | 263 | 0.080 |
Why?
| | Colonography, Computed Tomographic | 1 | 2010 | 8 | 0.080 |
Why?
| | American Heart Association | 2 | 2022 | 360 | 0.080 |
Why?
| | Coronary Artery Disease | 1 | 2017 | 760 | 0.080 |
Why?
| | Glomerulonephritis, IGA | 1 | 2009 | 12 | 0.080 |
Why?
| | Middle Aged | 7 | 2025 | 36176 | 0.080 |
Why?
| | Myocardial Perfusion Imaging | 2 | 2020 | 51 | 0.070 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1392 | 0.070 |
Why?
| | Ventricular Remodeling | 2 | 2022 | 277 | 0.070 |
Why?
| | Myocardial Contraction | 2 | 2020 | 291 | 0.070 |
Why?
| | Adnexal Diseases | 1 | 2008 | 2 | 0.070 |
Why?
| | Ovarian Cysts | 1 | 2008 | 6 | 0.070 |
Why?
| | Age Determination by Skeleton | 1 | 2008 | 16 | 0.070 |
Why?
| | Pericardial Effusion | 1 | 2008 | 22 | 0.070 |
Why?
| | Bacteremia | 1 | 2010 | 223 | 0.070 |
Why?
| | Thyroid Hormones | 1 | 2008 | 68 | 0.070 |
Why?
| | Pregnancy | 4 | 2025 | 7197 | 0.070 |
Why?
| | Thyroid Gland | 1 | 2008 | 89 | 0.060 |
Why?
| | Pleural Effusion | 1 | 2008 | 59 | 0.060 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 207 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1216 | 0.060 |
Why?
| | Syndrome | 1 | 2008 | 380 | 0.060 |
Why?
| | Radiography, Thoracic | 1 | 2008 | 172 | 0.060 |
Why?
| | Pelvis | 1 | 2008 | 126 | 0.060 |
Why?
| | Puberty | 1 | 2008 | 135 | 0.060 |
Why?
| | Signal-To-Noise Ratio | 1 | 2025 | 73 | 0.060 |
Why?
| | Carbon Footprint | 1 | 2025 | 2 | 0.060 |
Why?
| | Blood Circulation | 1 | 2024 | 44 | 0.050 |
Why?
| | Motion | 1 | 2025 | 99 | 0.050 |
Why?
| | Hemorrhage | 1 | 2009 | 826 | 0.050 |
Why?
| | Aortic Aneurysm | 1 | 2024 | 70 | 0.050 |
Why?
| | Body Size | 1 | 2024 | 95 | 0.050 |
Why?
| | Time Factors | 3 | 2021 | 7171 | 0.050 |
Why?
| | Workflow | 1 | 2025 | 184 | 0.050 |
Why?
| | Risk Factors | 4 | 2021 | 10874 | 0.050 |
Why?
| | Actigraphy | 1 | 2024 | 147 | 0.050 |
Why?
| | Bromocriptine | 1 | 2022 | 31 | 0.050 |
Why?
| | Observer Variation | 1 | 2023 | 358 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2022 | 137 | 0.050 |
Why?
| | Climate Change | 1 | 2025 | 203 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2945 | 0.040 |
Why?
| | Prosthesis Design | 1 | 2024 | 360 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 411 | 0.040 |
Why?
| | Acute Kidney Injury | 1 | 2009 | 873 | 0.040 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 17 | 0.040 |
Why?
| | Adiposity | 1 | 2025 | 529 | 0.040 |
Why?
| | United States | 3 | 2024 | 16115 | 0.040 |
Why?
| | Creatinine | 1 | 2022 | 513 | 0.040 |
Why?
| | Iron-Binding Proteins | 1 | 2000 | 43 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 83 | 0.040 |
Why?
| | Norwood Procedures | 1 | 2020 | 32 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 1040 | 0.040 |
Why?
| | Bevacizumab | 1 | 2021 | 168 | 0.040 |
Why?
| | Recurrence | 1 | 2023 | 1142 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 45 | 0.040 |
Why?
| | Cation Transport Proteins | 1 | 2000 | 118 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 59 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 571 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 196 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2010 | 1953 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 146 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 149 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 81 | 0.040 |
Why?
| | Waiting Lists | 1 | 2021 | 266 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 2060 | 0.040 |
Why?
| | Biomarkers | 2 | 2022 | 4283 | 0.040 |
Why?
| | Autografts | 1 | 2019 | 55 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2022 | 765 | 0.040 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 75 | 0.040 |
Why?
| | Biliary Tract | 1 | 2018 | 14 | 0.030 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 162 | 0.030 |
Why?
| | Incidence | 2 | 2018 | 2915 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1269 | 0.030 |
Why?
| | Societies, Medical | 1 | 2022 | 898 | 0.030 |
Why?
| | Cardiovascular System | 1 | 2019 | 137 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2019 | 369 | 0.030 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 82 | 0.030 |
Why?
| | Pyrimidines | 1 | 2021 | 520 | 0.030 |
Why?
| | Cardiac Output | 1 | 2017 | 179 | 0.030 |
Why?
| | Sulfonamides | 1 | 2021 | 581 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1896 | 0.030 |
Why?
| | Algorithms | 1 | 2025 | 1855 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 733 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 57 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1755 | 0.030 |
Why?
| | Oxygen | 1 | 2018 | 986 | 0.020 |
Why?
| | Ultrasonography, Doppler | 1 | 2014 | 126 | 0.020 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 249 | 0.020 |
Why?
| | Triplets | 1 | 2012 | 3 | 0.020 |
Why?
| | Pregnancy, Multiple | 1 | 2012 | 18 | 0.020 |
Why?
| | Blood Pressure | 1 | 2019 | 1782 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 297 | 0.020 |
Why?
| | Angiography | 1 | 2012 | 211 | 0.020 |
Why?
| | Bronchoscopy | 1 | 2012 | 227 | 0.020 |
Why?
| | Airway Obstruction | 1 | 2012 | 154 | 0.020 |
Why?
| | Ireland | 1 | 2010 | 32 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 505 | 0.020 |
Why?
| | Cesarean Section | 1 | 2012 | 230 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2018 | 1244 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2425 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 317 | 0.020 |
Why?
| | Methylprednisolone | 1 | 2009 | 58 | 0.020 |
Why?
| | Reoperation | 1 | 2012 | 631 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1895 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1511 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 3076 | 0.020 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 383 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 478 | 0.010 |
Why?
| | Renal Dialysis | 1 | 2009 | 465 | 0.010 |
Why?
| | Aged | 2 | 2019 | 26125 | 0.010 |
Why?
| | COS Cells | 1 | 2000 | 177 | 0.010 |
Why?
| | Gene Dosage | 1 | 2000 | 148 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 375 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2000 | 563 | 0.010 |
Why?
| | Transfection | 1 | 2000 | 925 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8326 | 0.010 |
Why?
| | Rats | 1 | 2000 | 5581 | 0.010 |
Why?
| | Mice | 1 | 2000 | 18338 | 0.000 |
Why?
| | Animals | 1 | 2000 | 38141 | 0.000 |
Why?
|
|
Browne's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|